Contract award record
TPOXX® Antiviral Treatment (Tecovirimat)
Notice details
- Published
- Category
- goods
- Buyer region
- London
- Source
- View official notice
Public buyer and contract winner
Public buyer
Department of Health and Social Care (DHSC)awarded to
Contract winner
MERIDIAN MEDICAL TECHNOLOGIES LIMITEDAward value£1
- AwardedCompleted
- StartCompleted
- EndCompleted
Work description
The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.